Chronic mTOR activation promotes cell survival in Merkel cell carcinoma

Cancer Letters

Volumn 344, Issue 2, 2014, Pages 272-281

  Lin, Zhenyu ^a,e   McDermott, Amelia ^a   Shao, Lijian ^b   Kannan, Aarthi ^a   Morgan, Michael ^c   Stack, Brendan C ^a   Moreno, Mauricio ^a   Davis, Daniel A ^a   Cornelius, Lynn A ^d   Gao, Ling ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Autophagy; Cell death; Merkel cell carcinoma; MTOR inhibitor; MTOR pathway

Indexed keywords

CASPASE; MAMMALIAN TARGET OF RAPAMYCIN;

ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL DEATH; CELL SURVIVAL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MERKEL CELL TUMOR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS;

AUTOPHAGY; CELL DEATH; MERKEL CELL CARCINOMA; MTOR INHIBITOR; MTOR PATHWAY;

AMINO ACID CHLOROMETHYL KETONES; CARCINOMA, MERKEL CELL; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; FORMALDEHYDE; HUMANS; PARAFFIN EMBEDDING; PHAGOSOMES; PROTEIN KINASE INHIBITORS; SKIN NEOPLASMS; TISSUE FIXATION; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84893703100     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.11.005     Document Type: Article

References (51)

1. Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management, J. Clin. Oncol., 27 (2009) pp. 4021-4026.
2. Baehrecke E.H. Autophagic programmed cell death in Drosophila. Cell Death Differ. 2003, 10:940-945.
3. Becker J.C. Merkel cell carcinoma. Ann. Oncol. 2010, 21(Suppl. 7):vii81-vii85.
4. Bichakjian C.K., Lowe L., Lao C.D., Sandler H.M., Bradford C.R., Johnson T.M., Wong S.L. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007, 110:1-12.
5. Blobel G.A., Gould V.E., Moll R., Lee I., Huszar M., Geiger B., Franke W.W. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Lab Invest. 1985, 52:39-51.
6. Dowling R.J., Topisirovic I., Alain T., Bidinosti M., Fonseca B.D., Petroulakis E., Wang X., Larsson O., Selvaraj A., Liu Y., Kozma S.C., Thomas G., Sonenberg N. MTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 2010, 328:1172-1176.
7. Duncavage E.J., Zehnbauer B.A., Pfeifer J.D. Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod. Pathol. 2009, 22:516-521.
8. Elgendy M., Sheridan C., Brumatti G., Martin S.J. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol. Cell 2011, 42:23-35.
9. Engels E.A., Frisch M., Goedert J.J., Biggar R.J., Miller R.W. Merkel cell carcinoma and HIV infection. Lancet 2002, 359:497-498.
10. Fazi B., Bursch W., Fimia G.M., Nardacci R., Piacentini M., Di Sano F., Piredda L. Fenretinide induces autophagic cell death in caspase-defective breast cancer cells. Autophagy 2008, 4:435-441.
11. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
12. Garcia-Martinez J.M., Moran J., Clarke R.G., Gray A., Cosulich S.C., Chresta C.M., Alessi D.R. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (MTOR). Biochem. J. 2009, 421:29-42.
13. Grander D., Kharaziha P., Laane E., Pokrovskaja K., Panaretakis T. Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies. Autophagy 2009, 5:1198-1200.
14. Guo J.Y., Chen H.Y., Mathew R., Fan J., Strohecker A.M., Karsli-Uzunbas G., Kamphorst J.J., Chen G., Lemons J.M., Karantza V., Coller H.A., Dipaola R.S., Gelinas C., Rabinowitz J.D., White E. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011, 25:460-470.
15. Hafner C., Houben R., Baeurle A., Ritter C., Schrama D., Landthaler M., Becker J.C. Activation of the PI3K/AKT pathway in Merkel cell carcinoma. PLoS One 2012, 7:e31255.
16. Hosokawa N., Hara T., Kaizuka T., Kishi C., Takamura A., Miura Y., Iemura S., Natsume T., Takehana K., Yamada N., Guan J.L., Oshiro N., Mizushima N. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 2009, 20:1981-1991.
17. Houben R., Ortmann S., Schrama D., Herold M.J., Berberich I., Reichardt H.M., Becker J.C. Activation of the MAP kinase pathway induces apoptosis in the Merkel cell carcinoma cell line UISO. J. Invest. Dermatol. 2007, 127:2116-2122.
18. Hsieh A.C., Costa M., Zollo O., Davis C., Feldman M.E., Testa J.R., Meyuhas O., Shokat K.M., Ruggero D. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell 2010, 17:249-261.
19. Jung C.H., Jun C.B., Ro S.H., Kim Y.M., Otto N.M., Cao J., Kundu M., Kim D.H. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 2009, 20:1992-2003.
20. Kanzawa T., Germano I.M., Komata T., Ito H., Kondo Y., Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004, 11:448-457.
21. Kassem A., Schopflin A., Diaz C., Weyers W., Stickeler E., Werner M., Zur A. Hausen, frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res. 2008, 68:5009-5013.
22. Kirkin V., McEwan D.G., Novak I., Dikic I. A role for ubiquitin in selective autophagy. Mol. Cell 2009, 34:259-269.
23. Laane E., Tamm K.P., Buentke E., Ito K., Kharaziha P., Oscarsson J., Corcoran M., Bjorklund A.C., Hultenby K., Lundin J., Heyman M., Soderhall S., Mazur J., Porwit A., Pandolfi P.P., Zhivotovsky B., Panaretakis T., Grander D. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ. 2009, 16:1018-1029.
24. Laplante M., Sabatini D.M. MTOR signaling in growth control and disease. Cell 2012, 149:274-293.
25. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
26. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007, 8:741-752.
27. Mathew R., Karp C.M., Beaudoin B., Vuong N., Chen G., Chen H.Y., Bray K., Reddy A., Bhanot G., Gelinas C., Dipaola R.S., Karantza-Wadsworth V., White E. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
28. Menon S., Yecies J.L., Zhang H.H., Howell J.J., Nicholatos J., Harputlugil E., Bronson R.T., Kwiatkowski D.J., Manning B.D. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci. Signal 2012, 5:ra24.
29. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr. Opin. Cell Biol. 2010, 22:132-139.
30. Moll I., Bohnert E., Herbst C., Forster W., Moll R., Franke W.W. Establishment and characterization of two Merkel cell tumor cultures. J. Invest. Dermatol. 1994, 102:346-353.
31. Moll R., Franke W.W. Cytoskeletal differences between human neuroendocrine tumors: a cytoskeletal protein of molecular weight 46,000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms. Differentiation 1985, 30:165-175.
32. Mujumdar N., Saluja A.K. Autophagy in pancreatic cancer: an emerging mechanism of cell death. Autophagy 2010, 6:997-998.
33. Nardi V., Song Y., Santamaria-Barria J.A., Cosper A.K., Lam Q., Faber A.C., Boland G.M., Yeap B.Y., Bergethon K., Scialabba V.L., Tsao H., Settleman J., Ryan D.P., Borger D.R., Bhan A.K., Hoang M.P., Iafrate A.J., Cusack J.C., Engelman J.A., Dias-Santagata D. Activation of PI3K signaling in Merkel cell carcinoma. Clin. Cancer Res. 2012, 18:1227-1236.
34. Penn I., First M.R. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999, 68:1717-1721.
35. Quaglino D., Di Leonardo G., Lalli G., Pasqualoni E., Di Simone S., Vecchio L., Ventura T. Association between chronic lymphocytic leukaemia and secondary tumours: unusual occurrence of a neuroendocrine (Merkell cell) carcinoma. Eur. Rev. Med. Pharmacol. Sci. 1997, 1:11-16.
36. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
37. Shimizu S., Kanaseki T., Mizushima N., Mizuta T., Arakawa-Kobayashi S., Thompson C.B., Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 2004, 6:1221-1228.
38. Shuda M., Kwun H.J., Feng H., Chang Y., Moore P.S. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J. Clin. Invest. 2011, 121:3623-3634.
39. Shvets E., Fass E., Elazar Z. Utilizing flow cytometry to monitor autophagy in living mammalian cells. Autophagy 2008, 4:621-628.
40. Takeuchi H., Kondo Y., Fujiwara K., Kanzawa T., Aoki H., Mills G.B., Kondo S. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 2005, 65:3336-3346.
41. Tang F., Watkins J.W., Bermudez M., Gray R., Gaban A., Portie K., Grace S., Kleve M., Craciun G. A life-span extending form of autophagy employs the vacuole-vacuole fusion machinery. Autophagy 2008, 4:874-886.
42. Tanida I., Ueno T., Kominami E. LC3 and Autophagy. Methods Mol. Biol. 2008, 445:77-88.
43. Tresse E., Kosta A., Luciani M.F., Golstein P. From autophagic to necrotic cell death in Dictyostelium. Semin. Cancer Biol. 2007, 17:94-100.
44. Villeneuve N.F., Lau A., Zhang D.D. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid. Redox Signal 2010, 13:1699-1712.
45. Wander S.A., Hennessy B.T., Slingerland J.M. Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J. Clin. Invest. 2011, 121:1231-1241.
46. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 12:401-410.
47. Wirawan E., Vande Walle L., Kersse K., Cornelis S., Claerhout S., Vanoverberghe I., Roelandt R., De Rycke R., Verspurten J., Declercq W., Agostinis P., Vanden Berghe T., Lippens S., Vandenabeele P. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis. 2010, 1:e18.
48. Ye S., Fowler T.W., Pavlos N.J., Ng P.Y., Liang K., Feng Y., Zheng M., Kurten R., Manolagas S.C., Zhao H. LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1. PLoS One 2011, 6:e27285.
49. Yu K., Toral-Barza L., Shi C., Zhang W.G., Lucas J., Shor B., Kim J., Verheijen J., Curran K., Malwitz D.J., Cole D.C., Ellingboe J., Ayral-Kaloustian S., Mansour T.S., Gibbons J.J., Abraham R.T., Nowak P., Zask A. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res. 2009, 69:6232-6240.
50. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S., Baehrecke E.H., Lenardo M.J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304:1500-1502.
51. Zou C.F., Jia L., Jin H., Yao M., Zhao N., Huan J., Lu Z., Bast R.C., Feng Y., Yu Y. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. BMC Cancer 2011, 11:22.